Latest News and Press Releases
Want to stay updated on the latest news?
-
Heartland Oncology and Hematology Oncologist Named 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO)
-
EXTON, PA, May 01, 2025 (GLOBE NEWSWIRE) -- Patients with sickle cell disease (SCD) continue to face severe complications, despite advances in treatment that have helped mitigate some risks....
-
Wilmington, Delaware, April 23, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Point of Care Hematology Diagnostics Market - Global Opportunity Analysis and Industry...
-
MidAmerica Cancer Care (MACC) Opens New Medical Oncology Clinic in Kansas City, Kansas to provide enhanced cancer care to the Kansas City community.
-
EXTON, PA, March 26, 2025 (GLOBE NEWSWIRE) -- The hemophilia treatment landscape is rapidly evolving, with newly launched therapies and gene therapies joining factor replacement therapies,...
-
EXTON, PA, March 18, 2025 (GLOBE NEWSWIRE) -- Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare and debilitating blood disorder that affects approximately 8,000 to 10,000 people in North America...
-
STUDIO CITY, Calif., March 01, 2025 (GLOBE NEWSWIRE) -- Myeloma Action Month is an annual global awareness campaign that takes place every March to raise awareness and inspire action for multiple...
-
Aptose Announces Positive Clinical Safety Review and Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib
-
Aptose’s Frontline Triple Drug Therapy with Tuspetinib Achieves Notable Responses in Newly Diagnosed AML Patients in the Phase 1/2 TUSCANY Trial
-
Florida Oncology and Hematology and American Oncology Network Welcomes Board-Certified Oncologist and Hematologist, Dr. Michele Ramirez.